We’re just over halfway through 2018, so it’s a good time to take a step back and look at how investments have performed so far this year. As far as high-dividend stocks go, many have been under significant pressure thanks to rising interest rates. In fact, high-dividend stocks have underperformed the S&P 500 by more than 4 percentage points, as a group.
With that in mind, here are the five best-performing high-dividend stocks (defined as yields of 3% or more) on the S&P 500 through the first six months of 2018, followed by a brief discussion of why they’ve done so well.
Image Source: Getty Images.
Recent Stock Price
Year-to-Date Total Return
Best Stocks To Own For 2019: Enphase Energy, Inc.(ENPH)
- [By Chris Lange]
Enphase Energy, Inc. (NASDAQ: ENPH) saw shares up sharply on Wednesday after the firm announced that it would be acquiring SunPower Corp.’s (NASDAQ: SPWR) microinverter business. The transaction is expected to close at the end of the third quarter of 2018.
- [By Ethan Ryder]
Enphase Energy (NASDAQ:ENPH) shot up 1.2% during mid-day trading on Thursday . The company traded as high as $6.04 and last traded at $5.65. 83,628 shares traded hands during mid-day trading, a decline of 95% from the average session volume of 1,595,823 shares. The stock had previously closed at $5.72.
- [By Travis Hoium]
Shares of microinverter manufacturer Enphase Energy Inc (NASDAQ:ENPH) jumped as much as 14.8% in trading Thursday after announcing a new residential solar partner. Shares settled down somewhat late in the day but were still up 8.8% at 3:40 p.m. EDT.
- [By Maxx Chatsko]
Shares of Enphase Energy (NASDAQ:ENPH) jumped nearly 53% last month, according to data provided by S&P Global Market Intelligence. The provider of microinverters and energy storage products didn’t gain on any specific day for any specific reason, but rather recovered from a poor finish in 2018. While many stocks sank in December, investors suffered through a more prolonged slump with Enphase Energy. The company’s shares slid 30% in the second half of last year.
- [By Steve Symington, Travis Hoium, and Neha Chamaria]
We asked three top Motley Fool investors exactly that. Read on to learn why they think iQiyi (NASDAQ:IQ), XPO Logistics (NYSE:XPO), and Enphase (NASDAQ:ENPH) fit the bill.
Best Stocks To Own For 2019: Camping World Holdings, Inc. (CWH)
- [By Todd Campbell, Rich Smith, and Neha Chamaria]
There isn’t much love for Owens Corning (NYSE:OI), Camping World Holdings (NYSE:CWH), and Oceaneering International (NYSE:OII) on Wall Street right now, but that could be about to change. Some of our top Motley Fool investors think the tough times that have soured the mood of institutional investors on these stocks could be ending and that could make these stocks bargains worth buying.
- [By Logan Wallace]
ValuEngine lowered shares of Camping World (NYSE:CWH) from a sell rating to a strong sell rating in a research report sent to investors on Wednesday morning.
- [By Daniel Miller]
Shares of Camping World Holdings, Inc. (NYSE:CWH), a leader in outdoor and camping products offering vehicles, RV and camping gear, maintenance and repair, among other products, are up 10% as of 4:00 p.m. EDT Thursday after news of an acquisition.
Best Stocks To Own For 2019: Orocobre Limited (OROCF)
- [By ]
In April 2018, Nemaska (OTCQX:NMKEF) drew nearly $100 million in investment from Japan’s SoftBank (OTCPK:SFTBY) group in exchange for a 9.9% interest in the company and access to lithium hydroxide produced by the company. In March 2018, CATL the world’s soon-to-be largest lithium battery manufacturer purchased a controlling stake in the Quebec Lithium project in consideration for $66 million. In February 2018, Korean steel giant, POSCO (PKX) announced a supply agreement and investment into Australian lithium miner Pilbara Minerals (OTCPK:PILBF). In January 2018, Toyota Tsusho (OTCPK:TYHOF), the strategic trading arm of Toyota Motors, invested approximately A$300 million in Orocobre (OTCPK:OROCF) in consideration for 15% of the company. Now, in April 2018, Swedish battery start-up NorthVolt has announced that it has signed an agreement for the supply of up to 5,000 metric tons per year of lithium hydroxide produced at Nemaska Lithium’s commercial plant in Shawinigan, Quebec. In connection with the supply of lithium chemicals, NorthVolt has agreed to deliver to Nemaska a 10 million euro promissory note that can be converted into voting shares of NorthVolt.
- [By ]
Early-stage lithium producer Orocobre (OTCPK:OROCF) has been busy developing its Argentine flag-ship asset at Olaroz. The company has managed to scale up the asset to around 12,000 T / year LCE with a nameplate production capacity of 17,500 T / year. Although the company has not achieved full production capacity at its asset, it has moved ahead with joint venture partner Toyota Tsusho (OTCPK:TYHOF) to develop plans for Phase 2. In January 2018, Orocobre announced that Toyota Tsusho would invest nearly $300 million for a 15% stake in the company, along with plans to double production capacity at Olaroz to 42,000 T LCE / year. The joint venture is also building a lithium hydroxide facility in Japan which will supply the local battery supply chain.
Best Stocks To Own For 2019: Karyopharm Therapeutics Inc.(KPTI)
- [By Keith Speights]
Shares of Karyopharm Therapeutics (NASDAQ:KPTI) were soaring 16.8% higher as of 11:26 a.m. EDT on Friday after jumping as much as 27.5% earlier. The biotech announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) action date for the New Drug Application (NDA) for selinexor in treating relapsed refractory multiple myeloma. The FDA previously expected to complete its review by April 6, 2019, but now anticipates making an approval decision by July 6, 2019.
- [By Ethan Ryder]
Karyopharm Therapeutics Inc (NASDAQ:KPTI) major shareholder Ltd Chione sold 251,468 shares of the business’s stock in a transaction dated Tuesday, September 4th. The stock was sold at an average price of $20.94, for a total transaction of $5,265,739.92. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
- [By Logan Wallace]
Karyopharm Therapeutics (NASDAQ:KPTI) had its price target decreased by Wedbush from $19.00 to $14.00 in a research note issued to investors on Monday, The Fly reports. Wedbush currently has an outperform rating on the stock.